A day after the WHO suspended testing of hydroxychloroquine for Covid-19 patients, the Indian Council of Medical Research (ICMR) said the use of the drug as a prophylaxis has been approved based on observational studies in India, which have indicated anti-viral properties with no major side-effects.
The decision was taken during an emergency meeting at the Akal Takht's secretariat, with acting Jathedar Giani Kuldip Singh Gargajj announcing the decision.
In an interview with NDTV, Maharashtra Food and Drug Administration (FDA) commissioner Tukaram Mundhe says two of the three actors have replied to the show-cause notices
Comments
Post a Comment